US Apologizes for Criminal Human Experiment
Does an "apology" suffice for criminal experimentation designed to cause harm?
Former Sen Finance Committee Investigator Speaks Out
"What’s gone on with the pharmaceutical industry is a physician arms race to buy off doctors…"
Another Risk of Death Linked to Atypical Antipsychotics
"The risk was greater for individuals prescribed atypical rather than conventional drugs."
Antipsychotic Drugs and Risk of Venous Thromboembolism: Nested Case-Control Study BMJ
NY Times Corrects Gina Kolata Re: Alzheimer’s
Five weeks after publishing a grossly dis-informative front-page report by Gina Kolata about Alzheimer’s research,The New York Times published a lengthy three paragraph correction.
FDA Urges Florida Not to Bar Foster Kids From Psych Drug Trials
How many children in foster care serve as human guinea pigs in commercial drug trials?
FDA Expands Market for Another Toxic Antipsychotic
According to a report by the Associated Press, the FDA has approved expanded use of Merck’s toxic antipsychotic drug, Saphris, for treating acute manic-depressive behavior in adults. Antipsychotics (neuroleptics) are a controversial class of drugs: Risperdal (approved in 1993), Zyprexa (1994), Seroquel (1997), Abilify (2002), and Saphris (2009). These drugs’…
Child’s Ordeal Shows Risks of Antipsychotic Drugs for Young
The prescribed drugs transformed Kyle Warren from a rambunctious healthy child into a drooling, sedated, obese, “shell.”
Research Integrity: Don’t Mess With the DSMB
"The current way that DSMBs are constituted and report has resulted in a loss of faith." NEJM
Globalization of Pediatric Drug Trials–For Whose Benefit?
There is no evidence to indicate that children have been the beneficiaries of the Pediatric Exclusivity Provision of FDAMA (enacted in 1998): there is evidence that pharmaceutical companies have increased their profits from the legislation by at least $14 billion.
Making a Killing–Marketing Exercises by Dr. Carl Elliott
The catalyst for Dr. Elliott’s article was the tragic case of Dan Markingson, a 26-year old who committed suicide in May 2004, while enrolled in the CAFE trial, prescribed Seroquel. This case encapsulates the tragic consequences of a broken system which is not designed to detect the hazards for human subjects posed by market-driven research.
Anesthesiologist who Committed Major Fraud Claims Bipolar Defense
"He was one of the most prolific investigators in the area of postoperative pain management. His fraud sets back our knowledge in the field tremendously.” Dr. Steve Shafer, the editor in chief of Anesthesia & Analgesia.
Ana Cantu was a Human Guinea Pig in a Drug Trial for $4,800
"The study started out with 20 subjects…For about a week there were 14 subjects. Then they started dropping…Now, we’re down to 7."